Tessera
Folgen

Dr. Deepak L. Bhatt

@dlbhattmd.bsky.social

Deepak L. Bhatt, MD, MPH, MBA, FACC, FAHA, FESC, MSCAI, is the Director of the Mount Sinai Fuster Heart Hospital and the Dr. Valentin Fuster Professor of Cardiovascular Medicine (with Tenure) at the Icahn School of Medicine at Mount Sinai in New York City.

19 Posts76 Follower33 Folgt
Dr. Deepak L. Bhatt@dlbhattmd.bsky.social · 5mo ago

PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischemic events: an observational study academic.oup.com/eurheartj/ar... #cardiology #cardiovascular #prevention #cardiosky #medsky

PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study

AbstractBackground and Aims. Low-density lipoprotein cholesterol (LDL-C)-lowering therapies are proven effective in atherosclerotic cardiovascular disease

academic.oup.com

Dr. Deepak L. Bhatt@dlbhattmd.bsky.social · 5mo ago

PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischemic events: an observational study academic.oup.com/eurheartj/ar... #cardiology #cardiovascular #prevention #cardiosky #medsky

PCSK9 inhibitor treatment and outcomes in patients with atherosclerotic cardiovascular disease but without prior ischaemic events: an observational study

AbstractBackground and Aims. Low-density lipoprotein cholesterol (LDL-C)-lowering therapies are proven effective in atherosclerotic cardiovascular disease

academic.oup.com

Dr. Deepak L. Bhatt@dlbhattmd.bsky.social · last yr.

Just out in @science.org Translational Medicine - more data supporting the pleiotropic benefits of EPA: Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity www.science.org/doi/10.1126/... #cardiology #CardioSky #cardiovascular #MedSky #EndoSky

Icosapent ethyl reduces arterial thrombosis by inhibition of cyclooxygenase-1–induced platelet reactivity

Dose-dependent platelet inhibition by icosapent ethyl contributes to beneficial effects of polyunsaturated omega-3 fatty acids.

science.org

Dr. Deepak L. Bhatt@dlbhattmd.bsky.social · last yr.

#cardiology #cardiovascular #MedSky #EndoSky #CardioSky #RenalSky @thelancetendo.bsky.social @thelancet.bsky.social

The Lancet Diabetes & Endocrinology@thelancetendo.bsky.social · last yr.

The ischaemic benefit on both myocardial infarction & stroke has not been previously observed with other SGLT inhibitors & warrants investigation of combined SGLT1/SGLT2 inhibition as a possible underlying mechanism thelancet.com/journals/lan... #T2D #CVD #CKD #MedSky #EndoSky #CardioSky #RenalSky

Dr. Deepak L. Bhatt@dlbhattmd.bsky.social · last yr.

Potential impact of the ongoing VICTORION-1 PREVENT trial - bottom line, millions of patients could be eligible for therapy with inclisiran. #CardioSky #MedSky #Cardiology #Cardiovascular #Prevention @ajpcardio.bsky.social

American Journal of Preventive Cardiology@ajpcardio.bsky.social · last yr.

>23 million US adults meet criteria for the ongoing trial of inclisiran for primary prevention (VICTORION-1 Prevent), yet rates of lipid-lowering therapy use are low among this high-risk population. www.sciencedirect.com/science/arti... #CardioSky #MedSky

Dr. Deepak L. Bhatt@dlbhattmd.bsky.social · last yr.

Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy | NEJM AI ai.nejm.org/doi/full/10.... #cardiology #AI

Calibration of ECG-Based Deep-Learning Algorithm Scores for Patients Flagged as High Risk for Hypertrophic Cardiomyopathy

Despite optimism for the incorporation of deep-learning (DL) algorithms into clinical practice, there is a lack of prospective data on how U.S. Food and Drug Administration (FDA)–cleared algorithms...

ai.nejm.org